Share Twitter LinkedIn Facebook Email Nizar M. Tannir, MD, FACP, Professor and Deputy Chair, GU Medical Oncology, MD Anderson presents Cabozantinib is the best salvage therapy for RCC at the 2016 annual International Kidney Cancer Symposium.
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read